Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial [Phase 4]
A Phase 4 pragmatic intraclass evaluation trial of GliflOzin in elderly patients with Type 2 diabetes is ongoing, with uncertain status.
-
CLINICAL_TRIALS withdrawal · 2021-03-10Clinical Trial Update: Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease [Phase 3]
Phase 3 trial assessing liraglutide for metabolic profile in type 2 diabetes with cardiovascular disease was withdrawn.
-
FDA approval · 2021-03-09FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Ajanta Pharma USA Inc.)
FDA approved metformin hydrochloride as an original application generic product from Ajanta Pharma USA Inc.
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 clinical trial update for LY3209590 in adults with Type 2 Diabetes Mellitus; results have been posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus [NA]
A completed clinical trial evaluating GLP-1 receptor agonists on arterial stiffness, endothelial glycocalyx, and coronary flow reserve in pa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity [Phase 3]
Phase 3 trial investigating the effects of SGLT2 inhibition on myocardial insulin sensitivity in patients with type 2 diabetes mellitus and …
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: A Study With NLY01 in Subjects With Type 2 Diabetes [Phase 2]
Phase 2 trial update for NLY01 in subjects with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus [Phase 3]
Phase 3 randomized trial of rivoglitazone in type 2 diabetes mellitus was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial evaluating liraglutide for Type 2 Diabetes mellitus has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians [Phase 4]
Phase 4 trial update evaluating the effect of Soliqua on glucose variability in adults with Type 2 diabetes in South Asian patients.
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics [Phase 4]
A Phase 4 trial assessing the effectiveness of liraglutide added to high-dose insulin in patients with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Computerized Cognitive Training for Diabetic Elderly Veterans [Phase 4]
A Phase 4 trial update on computerized cognitive training for elderly veterans with Type 2 diabetes has completed enrollment with results po…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients [Phase 2]
Phase 2 clinical trial update investigating risk of hypoglycemia with sitagliptin in type 2 diabetes patients; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Psychological-behavioral Intervention to Increase Activity in Type 2 Diabetes [NA]
Completed clinical trial evaluating a psychological-behavioral intervention to increase activity in adults with Type 2 Diabetes.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of the Safety and Pharmacokinetics of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients With Type 2 Diabetes [Phase 2]
Phase 2 study evaluating safety and pharmacokinetics of the anti-inflammatory antibody MABp1 in patients with Type 2 Diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets [Phase 4]
Phase 4 clinical trial evaluating benefits of starting at various atorvastatin doses to achieve cholesterol targets.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia [Phase 4]
Phase 4 trial comparing atorvastatin to simvastatin in type 2 diabetes patients with hypercholesterolemia has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: A Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High Cholesterol [Phase 4]
Phase 4 trial update evaluating safety and efficacy of atorvastatin in patients with diabetes and high cholesterol has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus [Phase 4]
Phase 4 trial update on atorvastatin and LDL profile in type 2 diabetes patients; study is terminated.
-
CLINICAL_TRIALS research · 2021-02-18Clinical Trial Update: Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes [Phase 4]
A Phase 4 trial evaluating atorvastatin with omega-3 fatty acids for cardiovascular risk reduction in patients with type 2 diabetes has comp…
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST) [Phase 4]
Phase 4 trial evaluating different starting doses of atorvastatin to achieve cholesterol targets.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc [Phase 4]
Phase 4 trial comparing injection site pain between semaglutide and dulaglutide in study participants; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Dapagliflozin Effects on Epicardial Fat [Phase 4]
A Phase 4 trial evaluating the effects of dapagliflozin on epicardial fat in adults with type 2 diabetes has completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004) [Phase 3]
Phase 3 cardiovascular outcomes trial for ertugliflozin in type 2 diabetes patients with vascular disease completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics [Phase 3]
Phase 3 trial evaluating PGX (polymer) for glycemic control and weight loss in overweight/obese individuals with Type II diabetes; the study…